Skip to main content
Top
Literature
1.
go back to reference Kacar C, Gilgil E, Tuncer T, Butun B, Urhan S, Arikan V, Dundar U, Oksuz MC, Sunbuloglu G, Yildirim C, Tekeoglu I, Yucel G (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24:212–214CrossRefPubMed Kacar C, Gilgil E, Tuncer T, Butun B, Urhan S, Arikan V, Dundar U, Oksuz MC, Sunbuloglu G, Yildirim C, Tekeoglu I, Yucel G (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24:212–214CrossRefPubMed
2.
go back to reference Yenal O, Lav I, Bilecen L (1968) Epidemiological study on the infectious rheumatic syndrome in Turkey. II. Occurrence of rheumatoid arthritis in the Sagmalcilar district of Istanbul. Influencing of various factors and tuberculosis. Z Rheumaforsch 27:215–223PubMed Yenal O, Lav I, Bilecen L (1968) Epidemiological study on the infectious rheumatic syndrome in Turkey. II. Occurrence of rheumatoid arthritis in the Sagmalcilar district of Istanbul. Influencing of various factors and tuberculosis. Z Rheumaforsch 27:215–223PubMed
3.
go back to reference Madenci E, Guler M, Tosun M, Cakirbay H (2002) Prevalence of rheumatoid arthritis in a sample of the Turkish population. Pain Clinic 14:325–330CrossRef Madenci E, Guler M, Tosun M, Cakirbay H (2002) Prevalence of rheumatoid arthritis in a sample of the Turkish population. Pain Clinic 14:325–330CrossRef
4.
go back to reference Akar S, Birlik M, Gurler O, Sari I, Onen F, Manisali M, Tirpan K, Demir T, Meral M, Akkoc N (2003) The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Ann Rheum Dis 62:344 Akar S, Birlik M, Gurler O, Sari I, Onen F, Manisali M, Tirpan K, Demir T, Meral M, Akkoc N (2003) The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Ann Rheum Dis 62:344
5.
go back to reference Akar S, Birlik M, Gurler O, Sari I, Onen F, Manisali M, Tirpan K, Demir T, Meral M, Akkoc N (2004) The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 22:416–420PubMed Akar S, Birlik M, Gurler O, Sari I, Onen F, Manisali M, Tirpan K, Demir T, Meral M, Akkoc N (2004) The prevalence of rheumatoid arthritis in an urban population of Izmir-Turkey. Clin Exp Rheumatol 22:416–420PubMed
6.
go back to reference Silman AJ (2001) Inflammatory joint disease-rheumatoid arthritis. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases. Oxford University Press, Oxford, pp31–71 Silman AJ (2001) Inflammatory joint disease-rheumatoid arthritis. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases. Oxford University Press, Oxford, pp31–71
7.
go back to reference MacGregor AJ, Bamber S, Silman AJ (1994) A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol 21:1420–1426PubMed MacGregor AJ, Bamber S, Silman AJ (1994) A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of an analysis from a nationwide twin study. J Rheumatol 21:1420–1426PubMed
Metadata
Title
Epidemiology of Rheumatoid Arthritis in Turkey
Authors
Nurullah Akkoc
Servet Akar
Publication date
01-07-2006
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 4/2006
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-005-0092-2

Other articles of this Issue 4/2006

Clinical Rheumatology 4/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine